Finance

Lists
Why is PTIX down 2.52%?
Dive Deeper
PTIX:OTCMKTS
Protagenic Therapeutics Inc
$0.46
-2.52%
(-0.012) 1D
Nov 13, 4:00:00 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for PTIX...
Open
$0.47
High
$0.47
Low
$0.46
Mkt. cap
836.06K
Avg. vol.
1.18K
Volume
831.00
P/E ratio
0.16
52-wk high
$2.38
52-wk low
$0.13
EPS
$2.94
Beta
1.84
Shares outstanding
1.81M
No. of employees
2
Open
$0.47
High
$0.47
Low
$0.46
Mkt. cap
836.06K
Avg. vol.
1.18K
Volume
831.00
P/E ratio
0.16
52-wk high
$2.38
52-wk low
$0.13
EPS
$2.94
Beta
1.84
Shares outstanding
1.81M
No. of employees
2
News stories
From web sources and news partners
About Protagenic Therapeutics Inc
CEO-
Employees2
Founded1994
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websiteprotagenic.com
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
153.79K
157.94K
109.92K
26.90K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
771.32K
1.10M
784.31K
581.29K
Operating expense
925.10K
120.33K
961.25K
670.60K
Total operating expenses
925.10K
120.33K
961.25K
670.60K
Operating income
-925.10K
-120.33K
-961.25K
-670.60K
Other non operating income
3.14M
326.07K
-
-
EBT including unusual items
2.21M
5.08M
-963.62K
-667.19K
EBT excluding unusual items
2.21M
-1.11M
-950.28K
-667.19K
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
2.21M
5.08M
-963.62K
-667.19K
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
-
-
10.76K
3.41K
Interest expense
-
-1.31M
-
-
Net interest expenses
-
-1.31M
10.76K
3.41K
Depreciation and amortization charges
-
-
-
-
EBITDA
-912.53K
-108.83K
-952.94K
-667.69K
Gain or loss from assets sale
-
-7.31M
-
-
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps